Monthly Archives: June 2015

zoom
-

ASCO 2015 Round-Up: Immunotherapy in the Spotlight

As June marks Cancer Immunotherapy Awareness Month, I wanted to reflect on some of the key scientific takeaways from the American Society of Clinical Oncology’s (ASCO) annual meeting, and how these advancements are shaping the future of immunotherapy and our work at OncoSec. After digesting the news and outcomes, I’ve summarized my personal highlights and research insights from the week.

Continue reading

zoom
-

Upward and Onwards: OncoSec Moves to The NASDAQ Capital Market

On May 27th, we proudly announced that our common stock has been listed on The NASDAQ Capital Market. We’re very excited to be following an upward trajectory and expect this milestone will bring several benefits to the company, ranging from appealing to a broader set of investors to increasing the visibility of OncoSec’s capabilities.

Continue reading